Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorSouthwest Autism Research & Resource Center

About this trial

The study involves up to 5 visits for a fasting blood draw, behavioral assessments, and/or questionnaires. Other samples may be collected when appropriate.

This study is currently recruiting.

There is no cost for visits or study-related exams.

Eligibility criteria

Qualifiers

ASD, as defined by either a gold standard measure for ASD diagnosis, the Autism Diagnostic Observation Schedule (ADOS); the Autism Diagnostic Interview-Revised (ADI-R); and/or a comprehensive assessment that is consistent with ASD, in the opinion of the principal investigator. For those the PI believes a prospective diagnosis of ASD is warranted, a formal diagnostic assessment will be scheduled at screening.

0 years through 17 years 11 months of age

Disqualifiers

History of a significant adverse reaction to a prior blood draw

In females of reproductive age, pregnancy or plans to become pregnant

Any other historical event/information that may, in the opinion of the PI, be a reason to exclude the child from participation.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

500 Participants
are grouped into 9 trial groups

9

Trial groups

See each trial group below.

Sponsors and collaborators

Southwest Autism Research & Resource Center

Lead sponsor

State University of New York - Downstate Medical Center

Collaborator